Alzheon hits another dead end funding its Alzheimer's program, pulls second IPO attempt
If at first you don’t succeed… maybe it wasn’t such a good idea.
Alzheon has learned that the hard way as it withdraws its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
